Pinnacle Financial Partners Inc. grew its holdings in shares of Clorox Co (NYSE:CLX) by 19.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,478 shares of the company’s stock after purchasing an additional 578 shares during the period. Pinnacle Financial Partners Inc.’s holdings in Clorox were worth $517,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in CLX. Phocas Financial Corp. purchased a new position in shares of Clorox during the second quarter valued at approximately $167,000. Dupont Capital Management Corp purchased a new position in shares of Clorox during the third quarter valued at approximately $199,000. Smith Moore & CO. purchased a new position in shares of Clorox during the third quarter valued at approximately $204,000. Private Asset Management Inc. purchased a new position in shares of Clorox during the fourth quarter valued at approximately $208,000. Finally, WFG Advisors LP lifted its holdings in shares of Clorox by 7.2% during the second quarter. WFG Advisors LP now owns 1,571 shares of the company’s stock valued at $209,000 after purchasing an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 73.42% of the company’s stock.
Clorox Co (CLX) opened at $128.80 on Thursday. Clorox Co has a 1-year low of $124.09 and a 1-year high of $150.40. The firm has a market cap of $16,632.30, a P/E ratio of 23.24, a P/E/G ratio of 2.41 and a beta of 0.31. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86.
In other Clorox news, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 1.00% of the company’s stock.
Several equities analysts have recently issued reports on the stock. Jefferies Group reiterated a “hold” rating and set a $130.00 target price on shares of Clorox in a report on Wednesday, December 13th. Wells Fargo & Co reiterated a “hold” rating and set a $130.00 target price on shares of Clorox in a report on Wednesday, December 13th. Deutsche Bank assumed coverage on shares of Clorox in a report on Wednesday, December 13th. They set a “hold” rating and a $142.00 target price for the company. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $163.00 price objective for the company in a report on Monday, January 8th. Finally, Bank of America upgraded shares of Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 price objective for the company in a report on Thursday, January 4th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $132.46.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.